Back to top

If you wish to go to ZacksFunds.com, click OK. If you do not, click Cancel.

MARKET VECTORS PHARMACEUTICAL ETF: (PPH)

(Market Close from AMEX) As of Dec 26, 2014 03:59 PM ET

 Add to portfolio

$65.20 USD

65.2
52,362

+0.33 (0.51%)

Volume: 52,362

Zacks ETF Rank: 3 - Hold [?]     3    

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Quote Details

Previous Close 64.87
Open 64.99
Bid 63.98
Ask 66.35
Day Low-High 64.82-65.30
52wk Low-High 52.39-66.89
Volume 52,362
NAV (month end) 66.29
Premium (+)/Discount (-) (month end)-1.42

Zacks Premium Research for PPH

Zacks ETF Rank [?] Hold 3
ETF Risk [?] Med
ETF Research Report

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

ETF Expense Ratio

Expense Ratio 0.35%
Dividend (Yield) $1.03 (1.57%)
Issuer VAN ECK

Benchmark for PPH

MARKET VECTORS US LISTED PHARMA 25 INDEX

This benchmark index is a rules-based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.

Fund Summary for PPH

MARKET VECTORS PHARMACEUTICAL ETF

The Market Vectors Pharmaceutical ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors US Listed Pharmaceutical 25 Index. The Index is a rules based index intended to track the overall performance of 25 of the largest U.S. listed, publicly traded pharmaceutical companies.